Table of Content


Chapter 1   Methodology & Scope
1.1    Market scope & definitions
1.2    Base estimates & calculations
1.3    Forecast calculations
1.4    Data sources
1.4.1    Primary
1.4.2    Secondary
1.4.2.1    Paid sources
1.4.2.2    Public sources
Chapter 2   Executive Summary
2.1    Industry synopsis, 2021-2034
Chapter 3   Industry Insights
3.1    Industry ecosystem analysis
3.1.1    Factor affecting the value chain
3.1.2    Profit margin analysis
3.1.3    Disruptions
3.1.4    Future outlook
3.1.5    Manufacturers
3.1.6    Distributors
3.2    Supplier landscape
3.3    Profit margin analysis
3.4    Key news & initiatives
3.5    Regulatory landscape
3.6    Impact forces
3.6.1    Growth drivers
3.6.1.1    Growing demand for breast milk substitutes
3.6.1.2    Favorable regulatory outlook
3.6.1.3    Significant expansion of the baby food industry
3.6.2    Industry pitfalls & challenges
3.6.2.1    Price volatility of raw material
3.6.2.2    Contradictory scientific evidence of DHA benefits in infants
3.7    Growth potential analysis
3.8    Porter’s analysis
3.9    PESTEL analysis
Chapter 4   Competitive Landscape, 2024
4.1    Introduction
4.2    Company market share analysis
4.3    Competitive positioning matrix
4.4    Strategic outlook matrix
Chapter 5   Market Estimates & Forecast, By Content, 2021-2034 (USD Million) (Tons)
5.1    Key trends
5.2    30% - 40%
5.3    40% - 50%
Chapter 6   Market Estimates & Forecast, By End Use, 2021-2034 (USD Million) (Tons)
6.1    Key trends
6.2    0 – 3 years old
6.3    3 – 6 years old
6.4    Others (premature infants, 7+ years old)
Chapter 7   Market Estimates & Forecast, By Region, 2021-2034 (USD Million) (Tons)
7.1    Key trends
7.2    North America
7.2.1    U.S.
7.2.2    Canada
7.3    Europe
7.3.1    UK
7.3.2    Germany
7.3.3    France
7.3.4    Italy
7.3.5    Spain
7.3.6    Russia
7.4    Asia Pacific
7.4.1    China
7.4.2    India
7.4.3    Japan
7.4.4    South Korea
7.4.5    Australia
7.5    Latin America
7.5.1    Brazil
7.5.2    Mexico
7.6    MEA
7.6.1    South Africa
7.6.2    Saudi Arabia
7.6.3    UAE
Chapter 8   Company Profiles
8.1    Algarithm
8.2    Cellana
8.3    Far East Microalgae
8.4    Goerlich Pharma
8.5    Guangdong Runke Bio-Engineering
8.6    Henry Lamotte OILS
8.7    Hubei Fuxing Biotechnology
8.8    JC Biotech
8.9    Kingdomway Nutrition
8.10    Lonza
8.11    Meteoric Biopharmaceutical
8.12    Nordic Naturals
8.13    Polaris
8.14    Qingdao Keyuan Marine Biochemistry
8.15    Xiamen Huison Biotech